Synapse

← Paul M. Ridker

Papers by Paul M. Ridker

Page 8 · newest first

  1. Rosuvastatin for Primary Prevention Among Individuals With Elevated High-Sensitivity C-Reactive Protein and 5% to 10% and 10% to 20% 10-Year RiskCirculation Cardiovascular Quality and Outcomes · 2010
  2. Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomesMenopause The Journal of The North American Menopause Society · 2010
  3. On the Use of Variance per Genotype as a Tool to Identify Quantitative Trait Interaction Effects: A Report from the Women's Genome Health StudyPLoS Genetics · 2010
  4. Lipoprotein(a) and Risk of Type 2 DiabetesClinical Chemistry · 2010
  5. Association Between a Literature-Based Genetic Risk Score and Cardiovascular Events in WomenObstetrical & Gynecological Survey · 2010
  6. Relative Leukocyte Telomere Length and Risk of Incident Ischemic Stroke in Men: A Prospective, Nested Case-Control ApproachRejuvenation Research · 2010
  7. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetesHuman Molecular Genetics · 2010
  8. Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized TrialAnnals of Internal Medicine · 2010
  9. Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study PopulationsPLoS ONE · 2010
  10. A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African AmericansClinical Pharmacology & Therapeutics · 2010
  11. Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in WomenDiabetes · 2010
  12. Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or DyslipidemiaCirculation · 2010
  13. Gamma-glutamyl carboxylase and its influence on warfarin doseThrombosis and Haemostasis · 2010
  14. Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive ProteinCirculation · 2009
  15. Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide AnalysisPLoS Genetics · 2009
  16. A Common Variant at 9p21 Is Associated With Sudden and Arrhythmic Cardiac DeathCirculation · 2009
  17. Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-AnalysisDiabetes Care · 2009
  18. Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive ProteinCirculation Cardiovascular Quality and Outcomes · 2009
  19. Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 DiabetesJAMA · 2009
  20. Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in WomenCirculation · 2009
  21. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trialsBMJ · 2009
  22. The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular DiseaseJournal of Periodontology · 2009
  23. Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort studyBMJ · 2009
  24. Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification MeasuresAnnals of Internal Medicine · 2009
  25. Multimarker Approach Predicts Adverse Cardiovascular Events in Women Evaluated for Suspected Ischemia: Results from the National Heart, Lung, and Blood Institute–Sponsored Women's Ischemia Syndrome EvaluationClinical Cardiology · 2009
  26. Should patients with rheumatoid arthritis receive statin therapy?Arthritis & Rheumatism · 2009
  27. Comparison of LDL Cholesterol Concentrations by Friedewald Calculation and Direct Measurement in Relation to Cardiovascular Events in 27 331 WomenClinical Chemistry · 2009
  28. Novel Associations of CPS1, MUT, NOX4, and DPEP1 With Plasma Homocysteine in a Healthy PopulationCirculation Cardiovascular Genetics · 2009
  29. A Randomized Trial of Rosuvastatin in the Prevention of Venous ThromboembolismNew England Journal of Medicine · 2009
  30. Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionalsEuropean Heart Journal · 2009
  31. Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health StudyJournal of Hypertension · 2009
  32. Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive ProteinObstetrical & Gynecological Survey · 2009
  33. Novel Loci, Including Those Related to Crohn Disease, Psoriasis, and Inflammation, Identified in a Genome-Wide Association Study of Fibrinogen in 17 686 WomenCirculation Cardiovascular Genetics · 2009
  34. Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in WomenCirculation · 2009
  35. Polymorphism in the CETP Gene Region, HDL Cholesterol, and Risk of Future Myocardial InfarctionCirculation Cardiovascular Genetics · 2009
  36. An Evaluation of Candidate Genes of Inflammation and Thrombosis in Relation to the Risk of Venous ThromboembolismCirculation Cardiovascular Genetics · 2009
  37. A Meta-Analysis of Candidate Gene Polymorphisms and Ischemic Stroke in 6 Study PopulationsStroke · 2009
  38. Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary SyndromesArteriosclerosis Thrombosis and Vascular Biology · 2009
  39. Association between polymorphisms in the β2-adrenergic receptor gene with myocardial infarction and ischaemic stroke in womenThrombosis and Haemostasis · 2009
  40. Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER StudyClinical Chemistry · 2008
  41. C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular DiseaseClinical Chemistry · 2008
  42. Novel Association of HK1 with Glycated Hemoglobin in a Non-Diabetic Population: A Genome-Wide Evaluation of 14,618 Participants in the Women's Genome Health StudyPLoS Genetics · 2008
  43. Population-Based Genomewide Genetic Analysis of Common Clinical Chemistry AnalytesClinical Chemistry · 2008
  44. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk PredictionCirculation · 2008
  45. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine · 2008
  46. GOSR2 Lys67Arg Is Associated With Hypertension in WhitesAmerican Journal of Hypertension · 2008
  47. A Randomized Trial of Low-Dose Aspirin in the Prevention of Clinical Type 2 Diabetes in WomenDiabetes Care · 2008
  48. Genetic Loci Associated With Plasma Concentration of Low-Density Lipoprotein Cholesterol, High-Density Lipoprotein Cholesterol, Triglycerides, Apolipoprotein A1, and Apolipoprotein B Among 6382 White Women in Genome-Wide Analysis With ReplicationCirculation Cardiovascular Genetics · 2008
  49. Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications TrialDiabetes Care · 2008
  50. Differential Citation Rates of Major Cardiovascular Clinical Trials According to Source of FundingCirculation · 2008